Epidemiologic and Clinical Characteristics of Cardiomyopathies in Japan. Results From Nationwide Surveys.

• Matsumori Akira

  Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine

• Furukawa Yutaka

  Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine

• Hasegawa Koji

  Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine

• Sato Yukihito

  Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine

• Nakagawa Hideaki

  Department of Public Health, Kanazawa Medical University

• Morikawa Yuko

  Department of Public Health, Kanazawa Medical University

• Miura Katsuyuki

  Department of Public Health, Kanazawa Medical University

• Ohno Yoshiyuki

  Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine

• Tamakoshi Akiko

  Department of Preventive Medicine/Biostatistics and Medical Decision Making, Nagoya University Graduate School of Medicine

• Inaba Yutaka

  Department of Epidemiology and Environmental Health, Juntendo University School of Medicine

• Sasayama Shigetake

  Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine

• Co-research workers

  Co-research workers are listed in Appendix.

Bibliographic Information

Other Title

• Results From Nationwide Surveys

Abstract

Nationwide clinico-epidemiological surveys of cardiomyopathies in Japan were carried out. Disorders surveyed included idiopathic dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), restrictive cardiomyopathy (RCM), arrhythmogenic right ventricular dysplasia (ARVD), mitochondrial disease, Fabry's disease of the heart and prolonged Q-T interval syndrome. The total number of patients was estimated at 17,700 for DCM, 21,900 for HCM, 300 for RCM, 520 for ARVD, 640 for mitochondrial disease, 150 for Fabry's disease of the heart, and 1,000 for prolonged Q-T interval syndrome. The prevalence of both DCM and HCM was higher in men than women: the male-to-female ratios were 2.6 and 2.3 for DCM and HCM, respectively. Detailed data on patients with DCM or HCM were collected by a follow-up survey. In 1 year more patients with DCM (5.6%) died than with HCM (2.8%): congestive heart failure (CHF) and arrhythmias were the leading causes of death for DCM and HCM, respectively. Angiotensin converting enzyme inhibitors (64.6%) and β-adrenergic blockers (40.9%) are commonly used to treat the CHF complicating DCM and may be associated with the clinical improvement in a significant number of DCM patients. Thus, the nationwide surveys of Japanese patients have yielded important current epidemiological and clinical information on the characteristics of cardiomyopathies in Japan. (Circ J 2002; 66: 323 - 336)<br>

Journal

• Circulation Journal

  Circulation Journal 66 (4), 323-336, 2002

  The Japanese Circulation Society

Keywords

• Cardiomyopathy
• Epidemiology
• Prevalence

Details

• CRID: 1390001205104744832
• NII Article ID: 110002587617
• NII Book ID: AA11591968
• DOI: 10.1253/circj.66.323
• COI: 1:STN:280:DC%2BD383hvVKjuw%3D%3D
• ISSN: 13474820
• ISSN: 13469843
• ISSN: http://id.crossref.org/issn/13469843
• ISSN: http://id.crossref.org/issn/00471828
• PubMed: 11954944
• Web Site: http://www.jstage.jst.go.jp/article/circj/66/4/66_4_323/_pdf
• Web Site: https://search.jamas.or.jp/link/ui/2002199647
• Text Lang: en
• Data Source:
  • JaLC
  • Crossref
  • PubMed
  • CiNii Articles
• Abstract License Flag: Disallowed